Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

Novartis: OmalizumabAchieved all Targets in Phase III Safety Registration

An announcement made by the Swiss drugmaker Novartis AG (NVS: Quote) on Wednesday suggested about the late-breaking results omalizumab clearing all the primary and secondary endpoints of a pivotal Phase III safety registration study in chronic spontaneous urticaria or CSU.

It is a chronic and debilitating form of hives with partial approved treatment options. GLACIAL is considered as the second of three pivotal Phase III studies. These studies conduct analysis about the efficacy and safety of omalizumab in CSU.

The result derived from the study supported supported the efficacy, safety and tolerability of omalizumab in patients with refractory CSU. It is a kind of chronic and debilitating skin disease with obstinate itch and hives.

Near about 40 percent of CSU patients were unsuccessful on ntihistamines. These include those who were taking the approved dose even for the fourth time. The doses, in terms of official regulations are currently available only for treatment for CSU.

However, Omalizumab is presently not at all approved or indicated for CSU. Supervision of the submissions for omalizumab in CSU is scheduled for later times in the current year. It is a collaborated effort of Novartis and Genentech, Inc.

The data was brought forward for the first time at the European Academy of Allergy and Clinical Immunology-World Allergy Organization World Allergy and Asthma Congress 2013 in Milan which is located in Italy.

FrenchTribune Specials

St George's Hospital Trust chief sites financial troubles

The chairman of St George's Hospital Trust in London, Christopher Smallwood has said that financial troubles could have an impact on patient care andhospital budgets in the coming year.

Mr Smallwood warned that the financial troubles facing the NHS could leave employees unpaid in 2016. He said that the hospitals are facing a shortage of...

Most Popular

Chipotle shuts several stores on concerns of E. coli

Chipotle has announced that it is closing several of its...

450 hospitals to pay for settlement on cardiac implants

According to the latest reports, a total of more than...

Singing can be more effective in making babies stop crying

According to a new study, singing a more effective way...

Doctors mark World Stroke Day 2015 with increased awareness

Doctors and healthcare workers are marking this year's...


Can Greece Come out of Economic Problems: